Global Ragweed Pollen Allergy Treatment Market is estimated to be valued at US$ 836.9 million in 2020 and is expected to exhibit a CAGR of 4.6% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Increasing research & development, clinical trials, and product launches is supporting the growth of the global ragweed pollen allergy treatment market. Moreover, key players are highly focused on obtaining approvals and strategic licensing agreements of novel therapies is again fostering market growth.
For instance, in April 2014, the U.S. FDA approved Merck’s ‘Timothy Grass Pollen Allergen Extract’ sublingual tablet as immunotherapy for treatment of pollen-induced allergic rhinitis with or without conjunctivitis in children aged 5 years and older and adults up to 65 years of age. The tablet is a novel option for patients who are unable to take allergy shots.
To Get More Business Strategies Sample Copy of Report @ https://www.coherentmarketinsights.com/insight/request-sample/4054
For instance, in January 2018, a Viennese firm, Biomay AG entered a collaborative agreement with MedUni Vienna to move BM32 into phase III trials. The BM32 vaccine showed positive results in the clinical symptoms of seasonal ragweed/grass pollen allergy in the phase II trials. Although statistical significance was not reached regarding the primary endpoint, the treated-subjects of BM32 showed an improvement with regards to visual analog scale, symptom medication, asthma symptom scores, and in the Rhinoconjunctivitis Quality of Life Questionnaire. The vaccine is now scheduled for approval in 2021.
Global Ragweed Pollen Allergy Treatment Market – Impact Analysis of COVID-19
The COVID-19 outbreak has adversely affected the ragweed pollen allergy treatment market. It has become difficult for the researchers to conduct researches during this COVID-19 pandemic. People with ragweed pollen allergy are getting confused with the COVID-19 symptoms as the symptoms associated with both conditions are similar. Thus, the overall market is estimated to observe an optimistic growth during the COVID-19 pandemic.
Key players are increasing funding for research & development of novel treatment which is again propelling the growth of the global ragweed pollen allergy treatment market. Moreover, approvals of allergy drugs by various regulatory authorities and market consolidation is further boosting the market growth. For instance, in October 2017, Stallergenes Greer was acquired by Medic Savoure Ltd. to strengthen its global presence in the pollen allergy industry in Canada.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables& Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/4054
Key Takeaways of the Global Ragweed Pollen Allergy Treatment Market:
- The global ragweed pollen allergy treatment market is expected to exhibit a CAGR of 61% during the forecast period (2020-2027) due to the growing funding for research & development of novel therapies. For instance, in July 2019, a clinical stage biopharmaceutical company, ASIT Biotech, confirmed that the ASIT+ phase III clinical study in ragweed/grass pollen rhinitis prevention is continuing its transformation from research to late-stage of clinical development.
- Major players operating in the ragweed pollen allergy treatment market are ALK-Abello A/S, ASIT Biotech SA, Anergis SA, Biomay AG, and Astellas Pharma Inc., Thermo Fisher Scientific Inc, Siemens Healthcare Private Limited, Omega Diagnostics Group PLC, Stallergenes Greer, bioMerieux SA, Lincoln Diagnostics, Inc, HOB Biotech Group Corp Ltd, HYCOR Biomedical, Inc, Alcon, Hitachi Chemical Diagnostics, Inc, Quest Diagnostics Incorporated, Circassia, Immunomic Therapeutics, Inc, Novartis AG, Japan Tobacco Inc, GlaxoSmithKline plc, REGiMMUNE Co, Ltd, Sanofi, and Merck KGaA.
Purchase This Premium Report With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/4054
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Technological Advancements in Ragweed Pollen Allergy Treatment
- Need for Ragweed Pollen Allergy Treatment
- Recommendations and guidelines by regulatory bodies
- Key Developments
- Acquisition, Collaborations & Partnerships
- Epidemiology
- PEST Analysis
- Market Dynamics
- Global Ragweed Pollen Allergy Treatment Market, Impact of Coronavirus (Covid-19) Pandemic
- Pre COVID-19 Market Scenario
- Post COVID-19 Market Scenario
- Strategies
- Global Ragweed Pollen Allergy Treatment Market, By Drug Class, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Nasal Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Ragweed Pollen Allergy Treatment Market, By Distribution Channel, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Online Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/ragweed-pollen-allergy-treatment-market-3315
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837